Quote & Headlines
StockTalk
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Similarities Between the First Two Active Immunotherapies in CancerMichael Becker • Wed, Mar 30, 2011
-
Pfizer's Failure Provides Clarity for ArQuleOhad Hammer • Wed, Aug 25, 2010
-
India Markets Thursday Wrap-Up: Buying Intensifies in Later HoursEquitymaster • Thu, Jul 22, 2010
-
India Markets Monday Wrap-Up: Volatility Plagues the IndicesEquitymaster • Mon, Jul 19, 2010
-
Indian Markets Thursday Wrap-Up: Concerns over Stimulus WithdrawalEquitymaster • Thu, Jan 7, 2010
-
Brilinta Data Should Soothe Some of AstraZeneca's Patent Cliff WoesEP Vantage • Wed, Sep 2, 2009
-
Lilly and Daiichi Finally Receive Effient ApprovalEP Vantage • Wed, Jul 15, 2009
-
Generic Players Continue to Impress in H1EP Vantage • Thu, Jul 2, 2009
-
Stocks Affected by FDA Calendar of Expected Decision DatesMike Havrilla • Wed, Jan 14, 2009
To learn more about Seeking Alpha Pro, click here.
There are no Focus articles on DSKYY.PK.
-
Similarities Between the First Two Active Immunotherapies in CancerMichael Becker • Wed, Mar 30, 2011
-
Pfizer's Failure Provides Clarity for ArQuleOhad Hammer • Wed, Aug 25, 2010
-
India Markets Thursday Wrap-Up: Buying Intensifies in Later HoursEquitymaster • Thu, Jul 22, 2010
-
India Markets Monday Wrap-Up: Volatility Plagues the IndicesEquitymaster • Mon, Jul 19, 2010
-
Indian Markets Thursday Wrap-Up: Concerns over Stimulus WithdrawalEquitymaster • Thu, Jan 7, 2010
-
Brilinta Data Should Soothe Some of AstraZeneca's Patent Cliff WoesEP Vantage • Wed, Sep 2, 2009
-
Lilly and Daiichi Finally Receive Effient ApprovalEP Vantage • Wed, Jul 15, 2009
-
Generic Players Continue to Impress in H1EP Vantage • Thu, Jul 2, 2009
-
Stocks Affected by FDA Calendar of Expected Decision DatesMike Havrilla • Wed, Jan 14, 2009
There are no Transcripts on DSKYY.PK.
There are no News articles on DSKYY.PK.
Company Description
Currently, there's no company description for DSKYY.PK.